Drug repurposing and wide-range screening of inhibitors against SARS-CoV-2.
- Funded by Academy of Finland
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
Academy of FinlandPrincipal Investigator
Olli VapalahtiResearch Location
FinlandLead Research Institution
Helsingin yliopistoResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
Prophylactic use of treatmentsSpecial Interest Tags
N/AStudy Type
UnspecifiedClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable